China Isotope & Radiation Corporation is a leading Chinese enterprise specializing in the research, development, manufacture, and distribution of isotopes and radiation-related products. As the largest company of its kind in China and a major player in Asia, it offers a broad range of solutions across several sectors, including healthcare, industry, and agriculture. Its primary functions include producing and supplying radiopharmaceuticals for medical imaging and therapy, manufacturing nuclear medical equipment, providing radioactive source products, and offering industrial irradiation services such as sterilization for medical devices and food products. The company’s operations span over 50 production lines, delivering more than 70 types of nuclides and 300 different products, reflecting its significant technological and production capabilities. Serving as a subsidiary of China National Nuclear Corporation, China Isotope & Radiation Corporation is instrumental in advancing nuclear technology applications, particularly in the medical sector, where it supports diagnostics, cancer treatment, and laboratory services. Headquartered in Beijing and staffed by several thousand employees, the corporation plays an essential role in supporting both the modernization of China’s healthcare system and the nation’s broader industrial and agricultural sectors through its radiation-based solutions.